Drug intelligence / Profile preview

dutasteride + tadalafil

Development stage
Phase 3
Lead developer
Dongkook Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Dutasteride + tadalafil is a fixed-dose combination of two small molecule drugs used primarily in the management of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) in men. Dutasteride is a 5-alpha-reductase inhibitor that blocks the conversion of testosterone to dihydrotestosterone, leading to reduced prostate volume and improvement in urinary symptoms. Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor that increases blood flow by relaxing smooth muscle, improving both LUTS and erectile function. The combination has been shown to be effective and safe for male patients with moderate-to-severe LUTS/ED, though response may be diminished in those with certain prostate anatomical features[1][3]. This combination does not have a unique brand name formulation widely marketed as of now.

Other names
DKF-313DKF313DKF 313
02

Targets

PDE5 (Phosphodiesterase 5A)SRD5A1 (Steroid 5-alpha-reductase type 1)SRD5A2 (Steroid 5-alpha-reductase type II)

Beyond the preview

Go deeper on dutasteride + tadalafil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dutasteride + tadalafil.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call